Ultimovacs to Launch Phase II Combination Trial of UV1 in Lung Cancer (NSCLC)

NEXT STORY
IBA and RaySearch expand their partnership in proton therapy
PREV STORY
Ultimovacs to Launch Phase II Combination Trial of UV1 in Lung Cancer (NSCLC)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Orion Corporation: Transfer of 107,965 own B-shares on 1 March 2017

ORION CORPORATION         STOCK EXCHANGE RELEASE 1 MARCH 2017 at 19.00 EET                      Orion Corporation: Transfer ...

author_avatar
NASDAQ Market News

Kura Oncology to Present at J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a ...

author_avatar
NASDAQ Market News

NewYork-Presbyterian Named New York’s #1 Hospital in U.S. News & World Report’s ‘Best Hospitals’ for the 17th Year in a Row

New York, New York, Aug. 08, 2017 (GLOBE NEWSWIRE) -- NewYork-Presbyterian Hospital, one of ...

author_avatar
NASDAQ Market News